Pressure BioSciences Ultra Shear Technology Nanoemulsions Platform Targets Revolution in Effectiveness of Therapeutics via Improved Drug Delivery and Dosing Safety
Pressure BioSciences Ultra Shear Technology Nanoemulsions Platform Targets Revolution in Effectiveness of Therapeutics via Improved Drug Delivery and Dosing Safety PBI Announces Collaboration to Improve and Optimize SinuSys Corp's Lead Sinus Health Product Candidate for Commencement of Phase IIb Clinical Study News provided by Share this article Share this article SOUTH EASTON, Mass., Jan. 20, 2021 /PRNewswire/ -- Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" or the "Company"), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and platform te...
Source: prnewswire.com